NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- ASN Kidney Week 2025 Home Dialysis Sessions Posted 11-11-2025
- NKF and Vantive Launch a Home Dialysis Awareness and Education Campaign Posted 11-11-2025
- Vantive CONNECT is Powering a New Ecosystem Called HomeAdvantage Posted 11-11-2025
- AKF Free 1-day Dialysis at Home Event on November 20 at 11 AM ET Posted 10-14-2025

